방사선 검사 시장 규모, 점유율, 동향 분석 보고서 : 모달리티별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Radiology Procedures Market Summary

The global radiology procedures market size was estimated at USD 266.7 billion in 2025 and is estimated to reach at USD 356.5 billion by 2033, growing at a CAGR of 3.6% from 2026 to 2033. This robust growth is driven by increasing demand for early and accurate diagnosis, rising prevalence of chronic and lifestyle-related diseases, and rapid technological advancements in imaging modalities such as CT, and digital X-ray systems.

In addition, the expansion of healthcare infrastructure, growing awareness of preventive healthcare, and rising investments by key market players are expected to propel the market. Conditions such as cancer, cardiovascular diseases, neurological disorders, and diabetes require early, accurate, and non-invasive diagnosis, positioning radiology at the core of modern clinical decision-making. As healthcare systems prioritize early detection, precision medicine, and outcome-based care, reliance on imaging procedures continues to intensify across screening, diagnosis, treatment planning, and long-term monitoring.

Cancer remains one of the strongest demand generators for radiological procedures. According to the U.S. National Center for Health Statistics, approximately 1,958,310 new cancer cases and 609,820 cancer-related deaths were reported in the U.S. in 2023. Imaging modalities such as CT, X-ray, and mammography are indispensable throughout the oncology care pathway, supporting population screening, tumor detection, staging, surgical planning, treatment response assessment, and post-therapy surveillance. Surgeons increasingly depend on preoperative CT and MRI to accurately delineate tumor size, margins, and anatomical relationships, directly improving surgical precision and patient outcomes. As cancer incidence continues to rise globally, imaging volumes are expected to grow proportionally.

Moreover, the rapidly aging global population accelerating demand for radiology procedures worldwide. Older adults face a significantly higher risk of chronic illnesses, disabilities, and degenerative conditions, making diagnostic imaging essential for early detection, disease monitoring, and clinical decision-making. Multiple NCBI studies confirm that individuals aged 65 years and above are more susceptible to neurological disorders, Parkinson's disease, cardiovascular conditions, and musculoskeletal degeneration, all of which rely heavily on radiological evaluation. Demographic trends reinforce this demand surge. According to the World Health Organization (WHO), the global population aged 60 years and above increased from approximately 1 billion in 2020 to around 1.4 billion by 2030 and is expected to nearly double to 2.1 billion by 2050. This expansion is accompanied by a sharp rise in elderly patients with multiple comorbidities, including stroke, depression, dementia, and frailty. Age-related changes in muscle mass, bone density, and body composition increase the risk of falls, fractures, and injuries, directly driving demand for X-ray and CT-based diagnostic procedures in both emergency and routine care settings.

Rapid technological innovation is a powerful driver accelerating growth in the radiological procedures market, as advances in materials science, detector design, and artificial intelligence are transforming imaging performance, cost structures, and clinical workflows. Continuous improvements in X-ray detection technologies and AI-enabled imaging systems are expanding clinical applications, improving diagnostic accuracy, and increasing procedure volumes across hospitals and diagnostic imaging centers.

A notable example of next-generation innovation emerged in February 2026, when researchers at Florida State University (FSU) announced the development of new hybrid materials for advanced X-ray technologies. Led by Professor Biwu Ma, the research introduced organic metal halide complexes (OMHCs) and organic metal halide hybrids (OMHHs) a new class of materials that address longstanding limitations of conventional inorganic X-ray detectors. Traditional materials such as cadmium telluride (CdTe) and cadmium zinc telluride (CdZnTe) are rigid, expensive, energy-intensive to manufacture, and rely on toxic elements, which constrain scalability and sustainability.

Global Radiology Procedures Market Report Segmentation

This report forecasts revenue growth at global levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. Forthis study, Grand View Research has segmented the global radiology procedures market report based on modality, end use, and region:

• Modality Outlook (Revenue, USD Million, 2021 - 2033)
• X-Ray
  • Chest
  • Other Body Parts
• Mammography
• Computed Tomography
  • Head & Neck CT
  • Chest CT
  • Abdominal CT
  • Pelvic CT
  • Musculoskeletal CT
  • Vascular CT
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Diagnostic Imaging Centers
• Others
• Region Outlook (Revenue, USD Million, 2021 - 2033)
• International
• U.S.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Modality
  • 1.2.2. End Use
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Modality outlook
  • 2.2.2. End Use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Radiology Procedures Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Radiology Procedures Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Radiology Procedures Market: Modality Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Radiology Procedures Market: Modality Movement Analysis
• 4.3. Radiology Procedures Market by Modality Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. X-Ray
  • 4.5.1. X-Ray Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. Chest
    • 4.5.2.1. Chest Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. Other Body Parts
    • 4.5.3.1. Other Body Parts Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Mammography
  • 4.6.1. Mammography Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Computed Tomography
  • 4.7.1. Computed Tomography Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7.2. Head & Neck CT
    • 4.7.2.1. Head & Neck CT Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7.3. Chest CT
    • 4.7.3.1. Chest CT Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7.4. Abdominal CT
    • 4.7.4.1. Abdominal CT Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7.5. Pelvic CT
    • 4.7.5.1. Pelvic CT Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7.6. Musculoskeletal CT
    • 4.7.6.1. Musculoskeletal CT Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7.7. Vascular CT
    • 4.7.7.1. Vascular CT Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Radiology Procedures Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Radiology Procedures Market: End Use Movement Analysis
• 5.3. Radiology Procedures Market by End Use Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. Hospitals
  • 5.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Diagnostic Imaging Centers
  • 5.6.1. Diagnostic Imaging Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Radiology Procedures Market: Regional Estimates & Trend Analysis

• 6.1. Regional Dashboard
• 6.2. Regional Radiology Procedures Market Movement Analysis
• 6.3. Radiology Procedures Market: Regional Estimates & Trend Analysis by Modality & End-use
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.5. International
  • 6.5.1. International Radiology Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. U.S.
  • 6.6.1. U.S. Radiology Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. GE HealthCare
    • 7.2.1.1. Company Overview
    • 7.2.1.2. Financial Performance
    • 7.2.1.3. Product Benchmarking
    • 7.2.1.4. Strategic Initiatives
  • 7.2.2. Siemens Healthcare GmbH
    • 7.2.2.1. Company Overview
    • 7.2.2.2. Financial Performance
    • 7.2.2.3. Product Benchmarking
    • 7.2.2.4. Strategic Initiatives
  • 7.2.3. Koninklijke Philips N.V.
    • 7.2.3.1. Company Overview
    • 7.2.3.2. Financial Performance
    • 7.2.3.3. Product Benchmarking
    • 7.2.3.4. Strategic Initiatives
  • 7.2.4. Canon Medical Systems
    • 7.2.4.1. Company Overview
    • 7.2.4.2. Financial Performance
    • 7.2.4.3. Product Benchmarking
    • 7.2.4.4. Strategic Initiatives
  • 7.2.5. Hologic, Inc
    • 7.2.5.1. Company Overview
    • 7.2.5.2. Financial Performance
    • 7.2.5.3. Product Benchmarking
    • 7.2.5.4. Strategic Initiatives
  • 7.2.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
    • 7.2.6.1. Company Overview
    • 7.2.6.2. Financial Performance
    • 7.2.6.3. Product Benchmarking
    • 7.2.6.4. Strategic Initiatives
  • 7.2.7. FUJIFILM VisualSonics Inc.
    • 7.2.7.1. Company Overview
    • 7.2.7.2. Financial Performance
    • 7.2.7.3. Product Benchmarking
    • 7.2.7.4. Strategic Initiatives
  • 7.2.8. AGFA HealthCare
    • 7.2.8.1. Company Overview
    • 7.2.8.2. Financial Performance
    • 7.2.8.3. Product Benchmarking
    • 7.2.8.4. Strategic Initiatives
  • 7.2.9. Shimadzu Corporation
    • 7.2.9.1. Company Overview
    • 7.2.9.2. Financial Performance
    • 7.2.9.3. Product Benchmarking
    • 7.2.9.4. Strategic Initiatives
  • 7.2.10. Carestream Health
    • 7.2.10.1. Company Overview
    • 7.2.10.2. Financial Performance
    • 7.2.10.3. Product Benchmarking
    • 7.2.10.4. Strategic Initiatives